| Amber Postma, DO | |
|
17500 Se 392nd St, Auburn, WA 98092-9705 | |
| (253) 939-6648 | |
| Not Available |
| Full Name | Amber Postma |
|---|---|
| Gender | Female |
| Speciality | Osteopathic Manipulative Medicine |
| Experience | 9 Years |
| Location | 17500 Se 392nd St, Auburn, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437539616 | NPI | - | NPPES |
| 1437539616 | Medicaid | WA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Muckleshoot Indian Tribe | 5092724286 | 6 |
News Archive
The Global Hygiene Council, a group of leading health and hygiene experts from around the world, convened in collaboration with the Centers for Disease Control and Prevention to discuss how proper hygiene plays a critical role in preventing the spread of illness and improving health around the world.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
Gestational diabetes may increase the risk of blood vessel dysfunction and heart disease in offspring by altering a smooth muscle protein responsible for blood vessel network formation.
› Verified 5 days ago
| Entity Name | Muckleshoot Indian Tribe |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558448175 PECOS PAC ID: 5092724286 Enrollment ID: O20060417000580 |
News Archive
The Global Hygiene Council, a group of leading health and hygiene experts from around the world, convened in collaboration with the Centers for Disease Control and Prevention to discuss how proper hygiene plays a critical role in preventing the spread of illness and improving health around the world.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
Gestational diabetes may increase the risk of blood vessel dysfunction and heart disease in offspring by altering a smooth muscle protein responsible for blood vessel network formation.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber Postma, DO 17500 Se 392nd St, Auburn, WA 98092-9705 Ph: (253) 939-6648 | Amber Postma, DO 17500 Se 392nd St, Auburn, WA 98092-9705 Ph: (253) 939-6648 |
News Archive
The Global Hygiene Council, a group of leading health and hygiene experts from around the world, convened in collaboration with the Centers for Disease Control and Prevention to discuss how proper hygiene plays a critical role in preventing the spread of illness and improving health around the world.
Many more stroke patients could benefit from thrombolytic treatment (the use of drugs to break up or dissolve blood clots), but it needs to be administered as quickly as possible after the first signs of illness, according to new findings from the largest meta-analysis to date investigating the clot-busting drug alteplase.
Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, said today that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc., headquartered in Argentina, and its affiliates in Peru, Colombia, Bolivia, Panama and Puerto Rico.
BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.
Gestational diabetes may increase the risk of blood vessel dysfunction and heart disease in offspring by altering a smooth muscle protein responsible for blood vessel network formation.
› Verified 5 days ago
Dr. Esther Miriam Johnston, M.D., M.P.H. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 923 Auburn Way N, Auburn, WA 98002 Phone: 253-351-3900 | |
Sheila Z Kennedy, D.O. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 820 Harvey Rd, Ste E, Auburn, WA 98002 Phone: 253-939-1066 Fax: 253-939-1069 | |
Dr. Kanwardeep Kaur Sidhu, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 205 10th St Ne, Ste 200, Auburn, WA 98002 Phone: 253-351-5300 Fax: 253-351-5399 | |
Sandra Kalvoda Ritland, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 17500 Se 392nd St, Auburn, WA 98092 Phone: 253-939-6648 Fax: 253-735-6705 | |
Dr. Russell William Faria, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 721 M St Ne Ste 100, Auburn, WA 98002 Phone: 253-735-0260 Fax: 253-735-0245 | |
Dr. David Bruce Rich, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 202 N Division St, Ste. 405, Plaza 2, Auburn, WA 98001 Phone: 253-939-3604 Fax: 253-735-4167 | |
Asra Razia Khan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 202 N Division St, Auburn, WA 98001 Phone: 253-333-2562 |